BETA Technologies Completes First Interstate Electric Aircraft Flights Under FAA Program, Carrying Artificial Organs

BETA Technologies Completes Historic First Interstate Electric Flights Under FAA Program, Carrying Artificial Organs

BETA Technologies has completed the first interstate electric aircraft flights conducted under the Federal Aviation Administration's eVTOL Integration Pilot Program (eIPP), marking a landmark milestone in the integration of Advanced Air Mobility (AAM) into the existing national airspace system.

Flight Route and Scale

The mission covered a total of approximately 275 nautical miles, spanning Virginia and Maryland. Stops included Blacksburg and Charlottesville in Virginia, as well as Frederick and Baltimore County in Maryland. The operation was supported by the Pennsylvania Department of Transportation, the Virginia Department of Aviation, and the Maryland Aviation Administration.

Record-High Participation in FAA eIPP

BETA Technologies was selected to participate in seven of the FAA's eight eIPP launch programs — the highest participation rate of any electric aircraft developer. The eIPP is designed to evaluate how eVTOL and other advanced aircraft can safely integrate into the current aviation system.

Artificial Organs on Board: A Breakthrough in Medical Logistics

The inaugural flights were completed in partnership with United Therapeutics, with artificial organs carried on board for actual delivery. The two companies are jointly developing both conventional takeoff and landing (CTOL) and vertical takeoff and landing (VTOL) electric aircraft for future organ transport missions, with goals of reducing costs, improving reliability, and cutting carbon emissions in time-sensitive medical logistics.

Unither Bioelectronics, a subsidiary of United Therapeutics, has entered into a deep collaboration with BETA covering autonomous flight technology, aircraft design, and charging infrastructure.

BETA Technologies Founder and CEO Kyle Clark stated: "United Therapeutics commissioned BETA to build electric aircraft capable of carrying life-saving cargo, and today we delivered on that promise. Our long-term partnership with United Therapeutics has shaped BETA's mission — to build aircraft, infrastructure, and an operating ecosystem… Today's successful mission lays the groundwork for routine medical applications via electric flight across the country, at dramatically lower cost."

Looking Ahead

The long-term goal for both companies is to significantly improve the affordability, reliability, and sustainability of organ transport compared to conventional delivery methods — by reducing costs and emissions — and to pioneer a more effective model for emergency medical logistics.

原文來源： 查看原文